Cite Filings / CTMX / 0000834237-22-006265

Feed Companies Filings Check

Sign in

SC 13G/A

Amended Statement of Ownership

CytomX Therapeutics, Inc. Filed 2022-02-03 Acc 0000834237-22-006265

Documents 1

SC 13G/A Amended Statement of Ownership , us23284f1057_020322.txt

Around this filing

2022-02-09 SC 13G/A Amended Statement of Ownership
2022-02-04 4 General Counsel acquired 22,500 shares (grant or award)
2022-02-04 4 Chief Medical Officer acquired 22,500 shares (grant or award)
2022-02-04 4 Chief Financial Officer acquired 22,500 shares (grant or award)
2022-02-04 4 President and CEO acquired 75,000 shares (grant or award)
2022-02-03 SC 13G/A Amended Statement of Ownership
2022-02-01 SC 13G/A Amended Statement of Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading us23284f1057_020322.txt…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…